High MYC mRNA expression is more clinically relevant than MYC DNA amplification in triple-negative breast cancer

Authors

Eriko Katsuta, Roswell Park Comprehensive Cancer Center
Li Yan, Roswell Park Comprehensive Cancer Center
Takashi Takeshita, Roswell Park Comprehensive Cancer Center
Kerry-Ann McDonald, Roswell Park Comprehensive Cancer Center
Subhamoy Dasgupta, Roswell Park Comprehensive Cancer Center
Mateusz Opyrchal, Washington University School of Medicine in St. Louis
Kazuaki Takabe, Roswell Park Comprehensive Cancer Center

Journal

International Journal of Molecular Sciences

Publication Date

2019

Volume

21

Issue

1

First Page

217

Document Type

Open Access Publication

DOI

10.3390/ijms21010217

Rights and Permissions

Katsuta E, Yan L, Takeshita T, McDonald K-A, Dasgupta S, Opyrchal M, Takabe K. High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 2020; 21(1):217. doi: 10.3390/ijms21010217.

Recommended Citation

Katsuta, Eriko; Yan, Li; Takeshita, Takashi; McDonald, Kerry-Ann; Dasgupta, Subhamoy; Opyrchal, Mateusz; and Takabe, Kazuaki, "High MYC mRNA expression is more clinically relevant than MYC DNA amplification in triple-negative breast cancer." International Journal of Molecular Sciences. 21, 1. 217 (2019).
https://digitalcommons.wustl.edu/open_access_pubs/8801